![](/img/cover-not-exists.png)
CN3 COST-EFFECTIVENESS OF IMATINIB VERSUS INTERFERON (IFN-a) PLUS LOW-DOSE CYTARABINE (ARA-C) FOR NEWLY DIAGNOSED CHRONIC PHASE CHRONIC MYELOID LEUKEMIA (CML) IN THE THE NETHERLANDS
MT Groot, KD Anstrom, SD Reed, CA Uyl-de GrootVolume:
7
Year:
2004
Language:
english
DOI:
10.1016/s1098-3015(10)65656-2
File:
PDF, 63 KB
english, 2004